Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) FCF Margin (2016 - 2025)

Historic FCF Margin for Wave Life Sciences (WVE) over the last 11 years, with Q2 2025 value amounting to 532.45%.

  • Wave Life Sciences' FCF Margin fell 3927000.0% to 532.45% in Q2 2025 from the same period last year, while for Sep 2025 it was 1108.71%, marking a year-over-year decrease of 8772900.0%. This contributed to the annual value of 140.32% for FY2024, which is 1221800.0% down from last year.
  • Latest data reveals that Wave Life Sciences reported FCF Margin of 532.45% as of Q2 2025, which was down 3927000.0% from 688.87% recorded in Q1 2025.
  • Wave Life Sciences' 5-year FCF Margin high stood at 657.69% for Q1 2023, and its period low was 9158.95% during Q3 2022.
  • Its 5-year average for FCF Margin is 1609.19%, with a median of 350.86% in 2021.
  • Per our database at Business Quant, Wave Life Sciences' FCF Margin plummeted by -90813000bps in 2022 and then soared by 90885300bps in 2023.
  • Over the past 5 years, Wave Life Sciences' FCF Margin (Quarter) stood at 399.32% in 2021, then crashed by -580bps to 2715.42% in 2022, then surged by 96bps to 115.62% in 2023, then decreased by -21bps to 139.75% in 2024, then tumbled by -281bps to 532.45% in 2025.
  • Its last three reported values are 532.45% in Q2 2025, 688.87% for Q1 2025, and 139.75% during Q2 2024.